BCKDHA Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 50.5 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control Adrenal gland
Negative control Target knockdown/knockout
Important caveats
Reasons your observed band may differ from the expected size.
Calculated mass50.5 kDa
LocalizationMitochondrion matrix
Processing / PTMRecord-dependent
ReactivityHuman / Mouse / Rat

Sample controls for BCKDHA Western blot

🧪Use Adrenal gland as the first positive-control candidate; no defensible HPA Not detected tissue was available, so use a target knockdown/knockout negative control.
Positive control: Adrenal gland (High)
Negative control: Target knockdown/knockout
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for BCKDHA

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Breast Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →
Bone marrow Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

Tissue Cell type Level Evidence Source

No HPA Not detected tissue is available; use a target knockdown/knockout negative control.

Section 1

What Is the Expected BCKDHA Western Blot Band Size?

Use the product-observed 50.5 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
50.5 kDaMatches the authoritative product WB observation.
50.5 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected BCKDHA appearancePlan around 50.5 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band50.5 kDa; use this as the primary experimental expectation.
Calculated mass50.5 kDa from UniProt P12694; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A04561-1.
Why is my band missing or off?
SituationLikely causeNext action
50.5 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.
Section 2

Real Curated BCKDHA Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdrenal gland
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA04561-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 4

Advanced BCKDHA Western Blot Tips

Deeper troubleshooting and optimisation questions for BCKDHA, answered from its protein features.

Which band should guide the blot?
Use 50.5 kDa, the observation attached to the authoritative A04561-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 50.5 kDa expectation.
Which positive control should I start with?
Start with Adrenal gland, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use a target knockdown/knockout control when no HPA Not detected tissue is available.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for BCKDHA Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A04561-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC13042768, PMC9174284, PMC11194096.
Boster reagents

BCKDHA Western Blot Reagents

Human/Mouse/Rat-reactive BCKDHA Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for BCKDHA using A04561-1; observed band 50.5 kDa
Anti-BCKDHA Antibody Picoband®
Cat # A04561-1
Reactivity: Human, Mouse, Rat

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.